全球人工授精市场 – 2029 年行业趋势及预测

市场分析和规模

近年来，预计人工授精市场将在预测期内快速增长。根据 2012 年发表在《PLOS Medicine》杂志上的一项研究，2010 年全球约有 4850 万对夫妇无法生育。市场公司经常提供家用试剂盒，例如排卵试剂盒、妊娠检测试剂盒和授精设备。人工授精是一种医疗程序，涉及在不使用性交的情况下将精子有目的地注射到女性子宫中。最广泛使用的人工授精类型是宫内授精 (IUI)。不孕不育患病率的上升是推动人工授精市场向前发展的主要因素。

Data Bridge Market Research 分析称，2021 年人工授精市场价值为 21.9875 亿美元，预计到 2029 年将达到 40.9998 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 8.10%。Data Bridge Market Research 团队策划的市场报告包括深入的专家分析、患者流行病学、管道分析、定价分析和监管框架。

市场定义

 人工授精是一种辅助生殖技术，即将存活的精子注入雌性的输卵管、子宫颈或子宫。人工授精通过快速无痛的同源人工授精 (AIH) 或供精人工授精 (AID) 程序完成。人工授精目前广泛用于动物育种，以提高繁殖成功率并保护稀有和濒危物种。它还有助于避免因生殖器问题导致动物疾病和不育症的传播。

报告范围和市场细分

Artificial Insemination Market Dynamics

Drivers

• Increasing incidence of infertility

Infertility affects nearly 20 million women, according to the National Women's Health Resource Center. Total fertility is anticipated to decline from 2.43 to 2.39 (children per woman) between 2020 and 2030, according to the 2017 United Nations World Population Prospects report. The growing incidences of infertility among the world's population is propelling the artificial insemination market forward.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of artificial insemination market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

Furthermore, the rising preference of modern women on Planned Parenthood because of uninterrupted full time professional career will influence the growth of artificial insemination market. Along with this, increasing urbanization and rising level of disposable income are the driving factors accelerating the growth of the artificial insemination market. Also, changing lifestyle of people and rising awareness among individuals about alternative reproductive treatments are the major market drivers that will further escalate the growth of artificial insemination market.

Opportunities

• Increase in strategic collaborations and new product launches      

Moreover, the market's growth is fueled by an increase in the number of new product launch and strategic collaboration of leading market players. This will provide beneficial opportunities for the artificial insemination market growth.

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the artificial insemination market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with artificial insemination will obstruct the growth rate of market. The dearth of skilled professionals and lack of awareness will challenge the artificial insemination market. Additionally, impact of COVID-19 on supply chain and strict regulatory issues will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This artificial insemination market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial insemination market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Artificial Insemination Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The artificial insemination market was hampered by the supply chain slowness.

Global Artificial Insemination Market Scope

The artificial insemination market is segmented on the basis of type, product type, source type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Intrauterine Insemination
• Intracervical Insemination
• Intravaginal Insemination
• Intratubal Insemination

Product Type

• Insemination Kits
• 家庭受孕设备
• 配件

源类型

• AIH-丈夫
• AID-捐助者

最终用户

• 医院
• 生育诊所
• 诊所
• 其他的

人工授精市场区域分析/见解

对人工授精市场进行了分析，并按国家、类型、产品类型、来源类型和最终用户提供了市场规模见解和趋势。

人工授精市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美在人工授精市场占据主导地位，因为该地区拥有完善的医疗基础设施和技术进步。此外，主要关键参与者的存在和有利的规章制度将促进该地区市场的增长率。 

预计亚太地区在预测期内将实现增长，因为该地区不孕不育率不断上升，医疗保健行业也不断发展。此外，监管宽松也将促进该地区市场的增长率。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

人工授精市场还为您提供每个国家/地区资本设备医疗保健支出增长、人工授精市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对人工授精市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和人工授精市场份额分析

人工授精市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对人工授精市场的关注有关。

人工授精市场的一些主要参与者包括：

• Conceivex, Inc.（美国）
• 骄傲天使（英国）
• 富士胶片尔湾科学公司（美国）
• 高科技解决方案（美国）
• Rinovum Women's Health, LLC（美国）
• TenderNeeds 生育中心（美国）
• Biogenics Inc.（美国）
• LABOTECT GMBH（德国）
• Hamilton Thorne, Inc（美国）
• 尼康仪器公司（美国）
• Zander Scientific Inc.（美国）
• Surelife Pte Ltd.（新加坡）
• Genea Limited（澳大利亚）
• 北里公司 (日本)
• Rocket Medical plc（英国）
• Vitrolife（瑞典）

SKU-68170